The Impact of Comorbidity on Costs and Effects of Second-line Treatment among Elderly Metastatic Colon Cancer Patients

被引：0
|
作者：
Woldemichael, A. [1 ]
Onukwugha, E. [1 ]
Zheng, Z. [1 ]
Hanna, N. [1 ]
Seal, B. S. [2 ]
Mullins, C. [1 ]
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Bayer Healthcare Phamaceuticals, Wayne, NJ USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2014年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [41] Is This Patient With Metastatic Bladder Cancer a Candidate for Second-Line Immunotherapy Treatment?
    Bourlon, Maria T.
    Velazquez, Hugo E.
    Luna-Santiago, Rodrigo
    Vazquez-Manjarrez, Sara
    Bourlon, Christianne
    [J]. ONCOLOGY-NEW YORK, 2018, 32 (02): : 64 - 68
  • [42] Is ramucirumab still the only second-line treatment in metastatic gastric cancer?
    El Gharib, Khalil
    Kourie, Hampig Raphael
    [J]. PHARMACOGENOMICS, 2020, 21 (17) : 1203 - 1206
  • [43] Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer
    Vyzula, R
    Kocáková, I
    Demlová, R
    Kiss, I
    Dusek, L
    Jarkovsky, J
    [J]. NEOPLASMA, 2006, 53 (02) : 119 - 127
  • [44] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
  • [45] Second-line systemic therapy for the treatment of metastatic renal cell cancer
    Kruck, Stephan
    Bedke, Jens
    Kuczyk, Markus A.
    Merseburger, Axel S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (06) : 777 - 785
  • [46] Second-line dovitinib in metastatic endometrial cancer
    Block, Matthew S.
    Dowdy, Sean C.
    [J]. LANCET ONCOLOGY, 2015, 16 (06): : 604 - 606
  • [47] Second-line management of metastatic colorectal cancer
    Gallagher, David J.
    Kemeny, Nancy
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 25 - 32
  • [48] Second-line therapy of metastatic bladder cancer
    Retz, M.
    Bokemeyer, C.
    [J]. ONKOLOGE, 2012, 18 (11): : 1018 - 1022
  • [49] Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA
    Hess, Lisa M.
    Cui, Zhanglin Lin
    Mytelka, Daniel S.
    Han, Yimei
    Goodloe, Robert
    Schelman, William
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (04) : 581 - 588
  • [50] A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancer
    Parmar, A.
    Richardson, M.
    Coyte, P. C.
    Cheng, S.
    Sander, B.
    Chan, K. K. W.
    [J]. CURRENT ONCOLOGY, 2020, 27 (04) : E386 - E394
12345